<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00573573</url>
  </required_header>
  <id_info>
    <org_study_id>GAAD-HT-CTP1</org_study_id>
    <nct_id>NCT00573573</nct_id>
  </id_info>
  <brief_title>Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism</brief_title>
  <official_title>Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GAAD Medical Research Institute Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GAAD Medical Research Institute Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to determine the possibility of using far infrared radiation to treat
      Hyperparathyroidism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in
      increased levels of calcium in the blood stream, which can lead to weakening of the bones and
      to kidney stones.

      We are postulating that the non-invasive energy specific electromagnetic radiation of the
      central nervous system, the viscera and the endocrine system has the potential to stop the
      over secretion of the parathyroid hormones and normalize the body's metabolic functions.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">July 2009</completion_date>
  <primary_completion_date type="Anticipated">March 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Far Infrared Radiation</intervention_name>
    <description>Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons with parathyroid disease

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Nedd, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>GAAD Medical Research Institute Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kwasi Donyina, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>GAAD Medical Research Institute Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Centre for Incurable Diseases</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4V 1L5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2007</study_first_submitted>
  <study_first_submitted_qc>December 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2007</study_first_posted>
  <last_update_submitted>March 23, 2009</last_update_submitted>
  <last_update_submitted_qc>March 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Kwasi Donyina/Founder and President</name_title>
    <organization>GAAD Medical Research Institute Inc.</organization>
  </responsible_party>
  <keyword>PRIMARY HYPERPARATHYROIDISM</keyword>
  <keyword>PARATHYROID NEOPLASMS</keyword>
  <keyword>SECONDARY HYPERPARATHYROIDISM</keyword>
  <keyword>HYPOCALCEMIA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

